Go to main contents Go to main menus

사용자별 맞춤메뉴

자주찾는 메뉴



contents area

detail content area


The Korea National Institute of Health (KNIH), a research organization under the Korea Centers for Disease Control and Prevention (KCDC) and Ministry of Health & Welfare is devoted for promoting the public health through the research on infectious and non-infectious diseases.

Viral hemorrhagic fevers are important causes resulting in major epidemics in Africa. Ensuring global health securities to hemorrhagic fever viruses, international cooperation is the most important for the prevention human infections. In this view, rapid and accurate detection for viral hemorrhagic fevers is one of important measures to prevent and control the human infections.

For this, KNIH has been developed the Real time RT-PCR method to detect viruses causing hemorrhagic fevers from clinical specimens. It is important to check its efficacy using human specimens. Therefore, KNIH would like to conduct a cooperative research for laboratory study with two African countries (institutes) on evaluation of Realtime RT-PCR kit to viral hemorrhagic fevers including Ebola, Marburg virus.

[Details of the Project]


      Establishment of research base center in Africa through international collaborative research for viral hemorrhagic fevers


      Two African countries (Institutes) will be selected
      A total of less than US$ 130,000 (₩ 150,000,000) for two African countries (Institutes) will be provided per year. Therefore, annual fund for one African country (Institute) should be less than US$ 65,000 (₩ 75,000,000) per year.
      The final budget will be adjusted with the results of evaluation

Research period

      July or August 2017 (after the contract) – December 2019
    • 1st year: July or August 2017 - December 31 2017
    • 2nd year: January 1 2018 - December 31 2018
    • 3rd year: January 1 2019 - December 31 2019

Field of Interesting

      Evaluation of Real time RT-PCR kit developed by KNIH to clinical samples for viral hemorrhagic fevers including ebola virus, Marburg virus, etc (on-site training, assessment, etc)
    • Collecting and securing the clinical sample : Positive and negative sera to viral hemorrhagic fevers (ebola virus, Marburg virus, etc.)
    • Processing the clinical specimens
    • Conducting the Real time RT-PCR
    • Analyze the results
      Sharing of research resources including clinical specimens and genetic materials
    1. Clinical specimens, Genetic materials


      Government Institute, University, Hospital, etc

Reporting system

      The Application should be written in MS word English and submitted before July 1, 2017 via e-mail
      The original documents (Government seal stamped, 10 copies) should be sent via air mail to following address after e-submission
      Documentation of the research project will be announced two Principal Investigators in African countries (institutes) after decision of granting

[Address for Airmail]

Division of New Emerging Infectious & Vector Research
Center for Infectious Diseases Research, National Institute of Health,
Korea Center for Disease Control and Prevention,
187, Osongsaengmyeong 2-ro, Cheongju-si,
Chungcheongbuk-do 28159, South Korea
TEL : +82-43-719-8494, FAX : +82-43-719-8519, email : ljyljy@nih.go.kr